Skip Nav Destination
1-9 of 9
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
A Multi-Center Quality Improvement Intervention to Reduce the Inappropriate Use of Aspirin Among Patients Anticoagulated with Warfarin for Atrial Fibrillation or Venous Thromboembolism
Jordan K Schaefer, MD, Josh Errickson, PhD, Xiaokui Gu, MA, Tina Alexandris-Souphis, RN, Mona A Ali, PharmD, Brian Haymart, RN, MS, Scott Kaatz, DO, MSc, Eva Kline-Rogers, RN, MS, Jay H Kozlowski, MD, Gregory D Krol, Suman L Sood, MD, James B Froehlich, MD MPH, Geoffrey D Barnes, MD MSc
Blood (2019) 134 (Supplement_1): 788.
Ijele Adimora, Brendan E Dempsey, BA, Youdinghuan Chen, MS, Kari Rosenkranz, MD, Deborah L. Ornstein, MD, Monic R. Drescher, MD
Blood (2019) 134 (Supplement_1): 935.
Double Blind Randomized Control Trial of Postoperative Low Molecular Weight Heparin Bridging Therapy for Patients Who Are at High Risk for Arterial Thromboembolism (PERIOP 2)
Michael J. Kovacs, MD, Marc Rodger, MDMSc, Philip S. Wells, MDMSc,FRCP, Shannon M. Bates, MD MSc, Clive Kearon, MB, PhD, Mark Blostein, MDFRCPC, Alejandro Lazo-Langner, MD MSc, Susan Kahn, MD, Sam Schulman, MD PhD FRCPC, Elham Sabri, MSc, Susan Solymoss, MD, Timothy Ramsay, PhD, Luljeta Pallaveshi, RN, BA, David Anderson, MD
Blood (2018) 132 (Supplement 1): 424.
The Impact of Adding Aspirin to Warfarin without an Apparent Indication: An Exploration of Patients Anticoagulated for Atrial Fibrillation or Venous Thromboembolic Disease
Jordan K. Schaefer, MD, Nicole M. Souphis, Suman L. Sood, MD MSCE, Brian Haymart, RN, MS, Xiaokui Gu, MA, Eva Kline-Rogers, RN, MS, Steven L. Almany, MD, Jay H. Kozlowski, MD, Gregory D. Krol, MD, Scott Kaatz, DO, MSc, James B. Froehlich, MD MPH, Geoffrey D. Barnes, MD MSc
Blood (2017) 130 (Supplement 1): 220.
Blood (2015) 126 (23): 4540.
Patients’ Knowledge Of Anticoagulation and Its Association With Clinical Characteristics, INR Control and Warfarin-Related Adverse Events
Poupak Rahmani, MD, Ph.D., Charlotte L. Guzman, Mark D Blostein, M.D., Ashley Tabah, Alla Muladzanov, Susan R. Kahn, MD, MSc
Blood (2013) 122 (21): 1738.
Three-Month Cumulative Incidence of Thromboembolism and Bleeding After Periprocedural Anticoagulation Management of Patients with Active Cancer.
Alfonso J Tafur, M.D., Edyta Wolny, M.D., Ph.D., Robert McBane, II, M.D., Edyta Sutkowska, Joshua P Slusser, David O Hodge, MS, John A. Heit, Waldemar E Wysokinski, M.D., Ph.D.
Blood (2009) 114 (22): 491.
Should High-Risk Patients with Chronic Atrial Fibrillation and Those with Coronary Artery Disease Receive Combined Aspirin-Oral Anticoagulant Therapy or Oral Anticoagulant Therapy Alone? A Systematic Review and Meta-Analysis.
Blood (2005) 106 (11): 904.
Enoxaparin Is Effective and Safe as Bridging Anticoagulation in Patients with a Mechanical Prosthetic Heart Valve who Require Temporary Interruption of Warfarin because of Surgery or an Invasive Procedure.
Blood (2004) 104 (11): 703.